title: Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation.
authors.affiliation: Department of Cardiology, Oslo University Hospital, Oslo, Norway. einar.gude@rikshospitalet.no
authors.forename: Einar
authors.initials: E
authors.lastname: Gude
authors.forename: Lars
authors.initials: L
authors.lastname: Gullestad
authors.forename: Satish
authors.initials: S
authors.lastname: Arora
authors.forename: Svein
authors.initials: S
authors.lastname: Simonsen
authors.forename: Ina
authors.initials: I
authors.lastname: Hoel
authors.forename: Anders
authors.initials: A
authors.lastname: Hartmann
authors.forename: Hallvard
authors.initials: H
authors.lastname: Holdaas
authors.forename: Arnt E
authors.initials: AE
authors.lastname: Fiane
authors.forename: Odd R
authors.initials: OR
authors.lastname: Geiran
authors.forename: Arne K
authors.initials: AK
authors.lastname: Andreassen
mesh_terms: D065095:Calcineurin Inhibitors; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D000068338:Everolimus; D005260:Female; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate; D006084:Graft Rejection / Q000453:epidemiology / Q000628:therapy; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015994:Incidence; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D020127:Recovery of Function; D019233:Retreatment; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017741:Survivors; D013997:Time Factors
chemical_list: D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000068338:Everolimus; D003404:Creatinine; D020123:Sirolimus